Cholesteatoma
Also known as: Middle-ear cholesteatoma, Tympanomastoid cholesteatoma, Acquired cholesteatoma, Congenital cholesteatoma
Cholesteatoma is characterised by an abnormal accumulation of keratinising squamous epithelium within the middle ear or mastoid that can erode surrounding structures, impair hearing, and cause serious complications. Clinical management necessitates otolaryngology (ENT) assessment, audiometric evaluation, and typically surgical management, followed by continued surveillance because disease can recur. Chinese medicine care may be considered only for associated wellbeing concerns after medical assessment, not to remove cholesteatoma or restore damaged anatomy. The supplied surgical series describes selected reoperation cases, not population recurrence rates. None of the supplied abstracts establishes acupuncture or herbal efficacy for cholesteatoma. The facial-palsy review and qualitative study protocol concern different conditions, and records without abstracts cannot substantiate treatment claims.
Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.
Lifestyle & Diet
- •Adhere to all scheduled ENT, audiometric, and postoperative surveillance appointments, regardless of perceived symptomatic resolution.
- •Follow individual water precautions and abstain from swimming until cleared by the treating team.
- •Avoid the insertion of cotton swabs, instruments, herbal distillates, or any non-prescribed substances into the external auditory meatus.
- •Maintain a brief record of discharge, pain, hearing changes, dizziness, and functional difficulties to discuss at clinical review.
Cautions & Contraindications
- •Do not use acupuncture or herbs to postpone indicated surgery, postoperative assessment or surveillance. The reoperation series documents recurrence and structural problems but does not assess adjunctive treatments.[]
- •Avoid needling through infected skin, a draining ear region, or a recent surgical wound; defer local ear-region treatment until the surgeon has confirmed healing. This procedural precaution is not directly studied in the supplied surgical series.[]
- •New facial weakness is a reason to suspend routine adjunctive care and obtain urgent medical assessment, not an indication to treat presumed Bell’s palsy. The supplied facial-palsy review does not establish management of cholesteatoma-related palsy.[]
When to reassess or seek care again
If medically stable and cleared for adjunctive care, review after 2–4 weeks using a 0–10 rating for the targeted wellbeing symptom, sleep disruption, appetite and daily function. Track ear symptoms for referral, not as proof of disease clearance. Stop or revise adjunctive care if there is no meaningful benefit; refer promptly for worsening discharge, pain or hearing, and urgently for red flags. ENT-directed examination, audiometry and surveillance remain independent of symptom improvement.
Explore more diseases
Sources & Further Reading
Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.
- European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
- Zhonghua yi xue za zhi · 2026
- Frontiers in neurology · 2026
- PloS one · 2025
Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.
